BCL3 expression is strongly associated with the occurrence of breast cancer relapse under tamoxifen treatment in a retrospective cohort study

Patients with estrogen receptor positive breast cancer are usually receiving an anti-estrogen therapy by either aromatase inhibitors or selective estrogen receptor mediators such as tamoxifen. Nevertheless, acquired resistance to tamoxifen under treatment frequently hampers therapy. One proposed exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Czapiewski, Piotr, Cornelius, Maximilian, Hartig, Roland, Kalinski, Thomas, Haybaeck, Johannes, Dittmer, Angela, Dittmer, Jürgen, Ignatov, Atanas, Nass, Norbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989858/
https://www.ncbi.nlm.nih.gov/pubmed/35020071
http://dx.doi.org/10.1007/s00428-021-03238-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989858/
https://www.ncbi.nlm.nih.gov/pubmed/35020071
http://dx.doi.org/10.1007/s00428-021-03238-8

Ejemplares similares